MedStar Health Introduces TOUCH Thumb Joint Replacement in D.C. and Baltimore
Event summary
- MedStar Health surgeons performed the first TOUCH CMC1 thumb joint replacements in D.C. (April 2026) and Baltimore (June 2026).
- The TOUCH prosthesis received FDA premarket approval in 2025 after successful use in Europe since 2018.
- Procedure takes under an hour with same-day discharge, offering faster recovery than traditional trapezium removal surgery.
The big picture
MedStar Health's adoption of the TOUCH prosthesis represents a significant advancement in treating thumb carpometacarpal arthritis, addressing limitations of traditional surgical methods. The procedure's minimally invasive nature and preservation of natural anatomy align with broader trends toward precision medicine and faster patient recovery. With nearly five million Americans over 50 affected by this condition, successful implementation could position MedStar Health as a leader in specialized hand surgery.
What we're watching
- Adoption Pace
- How quickly the TOUCH prosthesis gains acceptance among hand surgeons beyond MedStar Health's regional footprint.
- Clinical Outcomes
- Whether long-term results match the promised advantages in recovery time and functional restoration.
- Market Expansion
- The pace at which similar joint-replacement technologies emerge for other small joints.
Related topics